The Chicago Entrepreneur

: Pfizer’s $43 billion bid for Seagen aims to broaden company’s cancer portfolio

Pfizer plans to pay $229 per share in cash for Seagen, whose stock soared more than 15% in trading on Monday afternoon. Pfizer’s shares gained about 1.7%.

Previous post Investing in 2023 is ‘definitely going to be rocky,’ advisor says. How to stay the course
Next post : Silicon Valley Bank: Here’s what happened to cause it to collapse